Variable | Males | Females | P-value |
---|---|---|---|
Age (years) | 54.95±11.15 | 56.42±9.08 | 0.328 |
Smoking (n, %) | 8(8.6) | 0(0) | 0.004 |
Drinking (n, %) | 8(8.6) | 0(0) | 0.004 |
BSA (m2) | 1.78±0.16 | 1.61±0.13 | <0.001 |
BMI (kg/ m2) | 24.20±3.18 | 24.01±3.27 | 0.686 |
Weight (kg) | 70.12±10.81 | 61.43±9.14 | <0.001 |
Height (cm) | 170.08±5.61 | 159.89±5.15 | <0.001 |
Hypertension (n, %) | 21(22.6) | 12(12.9) | 0.084 |
Hyperlipidemia (n, %) | 10(10.8) | 8(8.6) | 0.620 |
Diabetes (n, %) | 7(7.5) | 11(11.8) | 0.321 |
CAD (n, %) | 9(9.7) | 8(8.6) | 0.799 |
Stroke (n, %) | 4(4.3) | 4(4.3) | 1.000 |
SBP (mm Hg)* | 125 (120–130) | 125 (116.5–130) | 0.990 |
DBP (mm Hg)* | 74 (64–80) | 74 (64–80) | 0.737 |
Triglycerides (mmol/L)* | 1.31 (0.86–2.05) | 1.30 (0.99–1.87) | 0.540 |
Total cholesterol (mmol/L) | 4.72±1.02 | 4.81±1.13 | 0.566 |
LDL-C (mmol/L) | 2.92±0.86 | 2.96±0.91 | 0.782 |
HDL-C (mmol/L) | 1.11±0.31 | 1.15±0.32 | 0.342 |
FBG (mmol/L)* | 5.28 (4.91–5.74) | 5.40 (4.97–5.91) | 0.398 |
CRP (mg/L)* | 1.01 (0.47–3.35) | 1.11 (0.59–3.47) | 0.638 |
BUN (mmol/L)* | 6.70 (5.80–7.85) | 5.50 (4.70–6.70) | <0.001 |
SCR (umol/L) | 83.25±13.60 | 69.71±19.93 | <0.001 |
eGFR (ml/min/1.73m2) | 94.67±16.52 | 89.78±19.39 | 0.066 |
Amiodarone use (n, %) | 2(2.2) | 4(4.3) | 0.678 |
Diltiazem use (n, %) | 1(1.1) | 4(4.3) | 0.365 |
Statins use (n, %) | 8(8.6) | 5(5.4) | 0.388 |
Dioxin use (n, %) | 17(18.3) | 16(17.2) | 0.848 |
Insulin use (n, %) | 4(4.3) | 5(5.4) | 0.733 |